Hartford Balanced Income Fund A (HBLAX)
14.55
-0.14
(-0.95%)
USD |
Mar 04 2025
Returns Chart
Key Stats
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
-- | -- | -- | -- |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-- | -- | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks to provide current income with growth of capital as a secondary objective. Under normal circumstances, the Fund will target an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than 5%. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | Allocation |
Broad Category | Allocation |
Global Peer Group | Mixed Asset USD Bal - US |
Peer Group | Mixed-Asset Target Alloc Moderate Funds |
Global Macro | Mixed Asset HC Balanced |
US Macro | Mixed-Assets Target Allocation Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Balanced Funds |
Fund Owner Firm Name | Hartford Funds |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 05, 2025.
Asset Allocation
As of December 31, 2024.
Type | % Net |
---|---|
Cash | 0.54% |
Stock | 42.78% |
Bond | 54.82% |
Convertible | 0.00% |
Preferred | 0.10% |
Other | 1.75% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
JPMorgan Chase & Co | 1.71% | 251.26 | 0.40% |
UnitedHealth Group Inc | 1.38% | 477.00 | 0.50% |
ConocoPhillips | 1.32% | 88.34 | -2.54% |
Johnson & Johnson | 1.30% | 164.26 | -0.70% |
Pfizer Inc | 1.16% | 26.14 | 1.50% |
Gilead Sciences Inc | 1.14% | 115.61 | 0.76% |
OTHER ASSETS LESS LIABILITIES
|
1.14% | -- | -- |
Bank of America Corp | 1.09% | 42.38 | -0.68% |
ULTRA BOND MAR25
|
1.06% | -- | -- |
Merck & Co Inc | 0.92% | 92.67 | 0.12% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | 0.25% |
Actual Management Fee | 0.52% |
Administration Fee | -- |
Maximum Front Load | 5.50% |
Maximum Deferred Load | -- |
Maximum Redemption Fee | -- |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 2000.00 None |
Minimum Subsequent Investment | 50.00 None |
Basic Info
Investment Strategy | |
The Fund seeks to provide current income with growth of capital as a secondary objective. Under normal circumstances, the Fund will target an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than 5%. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | Allocation |
Broad Category | Allocation |
Global Peer Group | Mixed Asset USD Bal - US |
Peer Group | Mixed-Asset Target Alloc Moderate Funds |
Global Macro | Mixed Asset HC Balanced |
US Macro | Mixed-Assets Target Allocation Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Balanced Funds |
Fund Owner Firm Name | Hartford Funds |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM | -- |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Stock | |
Weighted Average PE Ratio | -- |
Weighted Average Price to Sales Ratio | -- |
Weighted Average Price to Book Ratio | -- |
Weighted Median ROE | -- |
Weighted Median ROA | -- |
ROI (TTM) | -- |
Return on Investment (TTM) | -- |
Earning Yield | -- |
LT Debt / Shareholders Equity | -- |
Bond | |
Yield to Maturity | -- |
Average Coupon | -- |
Calculated Average Quality | -- |
Effective Maturity | -- |
Nominal Maturity | -- |
Growth Metrics
EPS Growth (1Y) | 2.77% |
EPS Growth (3Y) | 14.91% |
EPS Growth (5Y) | 8.19% |
Sales Growth (1Y) | 1.16% |
Sales Growth (3Y) | 11.14% |
Sales Growth (5Y) | 6.91% |
Sales per Share Growth (1Y) | 3.05% |
Sales per Share Growth (3Y) | 10.68% |
Operating Cash Flow - Growth Ratge (3Y) | 9.91% |
As of December 31, 2024
Fund Details
Key Dates | |
Inception Date | 7/31/2006 |
Last Annual Report Date | 10/31/2024 |
Last Prospectus Date | 3/1/2024 |
Share Classes | |
HBLCX | C |
HBLFX | F |
HBLIX | Inst |
HBLRX | Retirement |
HBLSX | Retirement |
HBLTX | Retirement |
HBLVX | Retirement |
HBLYX | Inst |
Attributes | |
Index Fund | -- |
Inverse Fund | -- |
Leveraged Fund | -- |
Fund of Funds | No |
Currency Hedged Fund | -- |
Synthetic Replication Fund | No |
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:HBLAX", "name") |
Broad Asset Class: =YCI("M:HBLAX", "broad_asset_class") |
Broad Category: =YCI("M:HBLAX", "broad_category_group") |
Prospectus Objective: =YCI("M:HBLAX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |